Achondrogenesis type 2

From WikiMD.org
Jump to navigation Jump to search

Achondrogenesis type 2 (pronounced as a-kon-dro-gen-e-sis type two) is a rare, lethal genetic disorder affecting the development of the skeletal system in infants.

Etymology

The term "Achondrogenesis" is derived from the Greek words 'a' meaning without, 'chondro' meaning cartilage, and 'genesis' meaning formation. The term thus refers to a condition where there is a lack of cartilage formation. The "type 2" designation indicates the second of three identified types of this disorder, each with different genetic causes and physical manifestations.

Definition

Achondrogenesis type 2 is a severe form of dwarfism characterized by short limbs, a small body, and underdeveloped lungs. It is caused by mutations in the COL2A1 gene, which is responsible for the formation of type II collagen, a protein that adds structure and strength to connective tissues.

Symptoms

The symptoms of Achondrogenesis type 2 may include micrognathia (small jaw), hydrops fetalis (abnormal accumulation of fluid in the fetus), and polyhydramnios (excessive amniotic fluid).

Diagnosis

Diagnosis of Achondrogenesis type 2 is typically made through ultrasound imaging during pregnancy, revealing characteristic skeletal abnormalities. Postnatal diagnosis can be confirmed through genetic testing for mutations in the COL2A1 gene.

Treatment

There is currently no cure for Achondrogenesis type 2. Treatment is supportive and focuses on managing symptoms and complications.

Prognosis

The prognosis for Achondrogenesis type 2 is poor, with most infants not surviving beyond the neonatal period due to respiratory failure.

See Also

External links

Esculaap.svg

This WikiMD dictionary article is a stub. You can help make it a full article.


Languages: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski